Amyotrophic lateral sclerosis (ALS), also known as motor neurone disease (MND), is a progressive neurodegenerative disease affecting both upper and lower motor neurons. Dysphagia is one of the most clinically significant complications — approximately 80% of ALS patients develop swallowing difficulties within 2 years of diagnosis, and in bulbar-onset ALS, dysphagia may be the presenting symptom.
ALS simultaneously damages upper motor neurons (UMN) and lower motor neurons (LMN), each affecting swallowing differently:
| Damage Type | Swallowing Presentation |
|---|---|
| Bulbar palsy (LMN damage) | Tongue wasting and fasciculations; direct loss of swallowing muscle strength |
| Pseudobulbar palsy (UMN damage) | Swallowing coordination disorder; emotional lability; slowed but preserved reflex |
| Mixed (majority of ALS patients) | Features of both — complex, variable presentation |
Onset type significantly affects swallowing timeline:
| Symptom | Clinical Significance |
|---|---|
| Tongue fasciculations and wasting | Direct sign of lower motor neuron damage |
| Slow oral bolus formation and propulsion | Tongue weakness |
| Prolonged mealtimes (>45 minutes) | Signal to discuss PEG timing |
| Coughing or choking on thin liquids | Delayed pharyngeal swallow reflex |
| Drooling (sialorrhea) | Reduced automatic swallowing frequency — not increased saliva production |
| Voice changes (hypernasality, weak voice) | Soft palate and vocal cord involvement |
| Progressive weight loss | Caloric insufficiency from impaired intake |
Percutaneous endoscopic gastrostomy (PEG) is the most important medical decision in ALS nutritional management. Timing is everything:
| Indicator | Optimal PEG Window | Rationale |
|---|---|---|
| Forced vital capacity (FVC) | FVC >50% | Below 50%, procedural sedation risk rises sharply |
| Body weight | Before significant weight loss | Poor outcomes with severe cachexia |
| Mealtime duration | When meals consistently >45 min | Energy expenditure exceeds intake |
| VFSS findings | When repeated aspiration confirmed | Safety concern even with remaining oral intake |
Critical misconception to address: PEG is not a signal that oral eating must stop. Many patients continue enjoying oral food for comfort after PEG placement, with the tube ensuring nutritional adequacy. PEG placement while FVC is still adequate is much safer than waiting until the patient “can no longer eat.”
Common errors in PEG timing:
Many ALS patients use BiPAP (bilevel positive airway pressure) for respiratory support. Meals require careful coordination:
| Consideration | Recommendation |
|---|---|
| Remove BiPAP mask to eat | Limit mealtime to 30 minutes to minimise respiratory fatigue |
| Resume BiPAP promptly after eating | Do not delay — respiratory muscle fatigue accumulates |
| Night use + saliva | Monitor nocturnal aspiration risk; position management essential |
| Post-BiPAP meals | Allow 15–20 minute gap after BiPAP use before eating (reduce aerophagia) |
ALS patients have a metabolic rate 10–15% above normal, compounded by feeding inefficiency. Caloric targets are high:
| Strategy | Approach |
|---|---|
| Target caloric intake | 35–45 kcal/kg/day (adjusted for body weight) |
| High-fat foods | Avocado, coconut milk, olive oil, nut butters — maximum calorie density per volume |
| High-protein intake | 1.2–1.5 g/kg/day; soft-set eggs, silken tofu, fish purée |
| Small frequent meals | Every 2–3 hours rather than large meals |
| Oral nutritional supplements (ONS) | High-calorie compact formats (e.g., Ensure Plus, Fortisip) |
| Avoid effortful foods | High fibre, requires prolonged chewing, crumbles easily |
| ALS Stage | Recommended IDDSI Level |
|---|---|
| Early (mild slowing only) | Level 6–7 (soft and bite-sized, regular) |
| Mild-moderate (coughing on thin liquids) | Liquids: Level 2–3 (mildly/moderately thick); Food: Level 5–6 |
| Moderate-advanced | Liquids: Level 3–4; Food: Level 4–5 |
| Advanced (PEG-dependent) | Tube feeding; comfort oral intake if desired |
ALS-specific textures to avoid at all stages:
Drooling in ALS is caused by reduced swallowing frequency, not excess saliva production. Management options:
| Approach | Method |
|---|---|
| Positioning | Upright head position; avoid prolonged supine posture |
| Hyoscine (scopolamine) patch | Reduces secretions; discuss with neurologist |
| Glycopyrronium (glycopyrrolate) | Oral or sublingual; titrate to effect |
| Botulinum toxin injection | Into parotid/submandibular glands; repeat every 3–6 months |
| Suction device | For severe accumulation, especially at night |
| Strategy | Implementation |
|---|---|
| Head and trunk position | Minimum 60° upright during and 30 minutes after eating |
| Oral hygiene | Brush or clean mouth before and after every meal |
| Texture management | Strict adherence to SLP-prescribed IDDSI levels |
| Night positioning | Bed head elevated 30°; manage nocturnal secretions |
| Respiratory physiotherapy | Help clear secretions; cough-assist device if cough weakened |
ALS feeding decisions are deeply personal and ethically complex:
| Option | When Used | Description |
|---|---|---|
| Continue active PEG tube feeding | Patient wishes to extend life | May be used alongside ventilator support |
| Comfort feeding | Patient prioritises quality of life | Small oral intake for pleasure; caloric adequacy not the goal |
| Decline PEG | Patient autonomous choice | Legally protected in most jurisdictions; requires advance directive documentation |
| Withdraw tube feeding | Terminal phase, advance directive in place | Requires palliative care team involvement |
Key principle: The decision about tube feeding in ALS is not a medical decision — it is a values decision. Patients should receive clear, unbiased information about what PEG can and cannot provide, and document their wishes in an advance directive early, while communication ability is preserved.
| Resource | What It Offers |
|---|---|
| MND Association (UK) | 0808-802-6262; care information, financial support, equipment loan |
| ALS Association (US) | als.org; care centre network, research, practical support |
| Motor Neurone Disease Association (Australia) | mndaust.asn.au; state-based support coordinators |
| Speech-language pathologist (SLP) | Specialist in dysphagia — request referral at diagnosis, not when severe |
| Dietitian | Caloric tracking, PEG formula selection, weight monitoring |
| Palliative care team | Optimal to engage early in ALS course, not only end-stage |
ALS dysphagia is progressive and irreversible — early planning is the most important strategy to reduce suffering and maintain quality of life. PEG should be placed while FVC remains above 50% and weight is stable, not as a last resort. The optimal dietary approach emphasises maximum caloric density in minimal volume. IDDSI texture modification, strict BiPAP-meal coordination, and oral hygiene are the three pillars of daily care. End-of-life feeding decisions should be documented in an advance directive early in the disease course, when the patient is still fully able to communicate their values.